Kaiser Permanente is a clinical research site located in Portland, Oregon, United States 97227.
Crixeo Health Trust Score: 82/100 (GOOD). This profile has not yet been claimed by the site owner.
Kaiser Permanente has participated in 21 clinical trials with 1 currently active.
Therapeutic areas: Small Cell Lung Carcinoma, Adenocarcinoma of the Rectum, Stage II Rectal Cancer.
Sponsors: Bristol-Myers Squibb, ECOG-ACRIN Cancer Research Group, NSABP Foundation Inc.
Trust Score: 82/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Kaiser Permanente has a Crixeo Trust Score of 82/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Kaiser Permanente has 21 clinical trials on record, with 1 currently active. Their work covers Small Cell Lung Carcinoma, Adenocarcinoma of the Rectum, Stage II Rectal Cancer.
Yes — Kaiser Permanente holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.